Rebecca har mer enn 30 års erfaring innen influensaforskning. Nøkkelkompetansen til influensasenteret er utvikling og klinisk evaluering av nye og pandemiske vaksiner, samt kohortstudier av infiserte pasienter med fokus på immunologiske responser med langsiktig oppfølging.

Rebecca vant Meltzer-prisen for fremragende forskningsformidling i 2022 som en anerkjennelse for sitt arbeid innen offentlig formidling. Hun bidrar ofte til nyheter gjennom intervjuer og kronikker på TV, radio, i avisene, på nettet og magasiner om COVID-19, influensa og vaksiner, inkludert >400 medieintervjuer under COVID-pandemien.

Rebecca deltar aktivt i undervisningen i virologi, immunologi og vaksinologi for studenter og doktorgradsstudenter (master og doktorgrad, leger under spesialisering) innen medisin, farmasi, odontologi og cellebiologi. Hun leder utdanningsutvalget for det lærde samfunnet Influensa og andre luftveisvirus.

Faglig foredrag

• Cox Brokstad, Rebecca Jane (2024). Long Covid plager hos barn etter deltainfeksjon og omicron-reinfeksjon. (ekstern lenke)
• Cox Brokstad, Rebecca Jane (2024). Strategi for Influensavaksinasjon. (ekstern lenke)
• Cox, Rebecca Jane (2023). Correlates of Protection. (ekstern lenke)
• Cox, Rebecca Jane (2023). Human Challenge Models panel discussion. (ekstern lenke)
• Cox, Rebecca Jane (2022). Influensavaksiner og covid vaksiner . (ekstern lenke)
• Cox, Rebecca Jane (2022). Post-covid: Balancing concerns for public health and individual autonomy over own health. The specialist/immunology perspective. (ekstern lenke)
• Cox, Rebecca Jane (2022). Influenza. (ekstern lenke)
• Cox, Rebecca Jane (2021). Overview of novel platforms in influenza vaccine and integrating lessons from COVID-19. (ekstern lenke)
• Cox, Rebecca Jane (2021). Covid-19 infection and vaccination in Western Norway . (ekstern lenke)
• Cox, Rebecca Jane (2021). Vaksinasjon og COVID-19 vaksiner. (ekstern lenke)
• Cox, Rebecca Jane (2020). Immunitet til COVID-19 i Bergen. (ekstern lenke)
• Cox, Rebecca Jane (2020). Sanntidsforskning: Når egen forskning blir livsviktig og dagsaktuell/vitenskapsrådgivning. (ekstern lenke)
• Cox, Rebecca Jane (2018). Vaksinering av helsepersonell hva vet vi?. (ekstern lenke)

Kronikk

• Grødeland, Gunnveig; Cox, Rebecca Jane; Mohn, Kristin Greve-Isdahl et al. (2024). Hvor bekymret skal vi være for fugleinfluensa? Ganske. . (ekstern lenke)
• Brokstad, Rebecca Jane Cox; Brokstad, Karl Albert (2020). CoVid-19; Derfor vil ikke dødeligheten være stor hvis viruset spres i Norge Norsk helsevesen er godt forberedt på at Wuhan-viruset kan spre seg til landet og beredskapen er på plass.. (ekstern lenke)
• Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox (2020). Det er ikke bare antistoffer som beskytter mot covid-19.. (ekstern lenke)
• Brokstad, Rebecca Jane Cox; Brokstad, Karl Albert (2020). Not just antibodies: B cells and T cells mediate immunity to COVID-19.. (ekstern lenke)
• Ertesvåg, Nina; Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2018). Få en influensafri jul!. (ekstern lenke)
• Cox, Rebecca Jane; Mohn, Kristin Greve Isdahl (2017). Nok tro og folelser na. (ekstern lenke)
• Cox, Rebecca Jane; Mohn, Kristin Greve Isdahl (2017). Gravide – se opp for fake news!. (ekstern lenke)
• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2015). Sølje Bergman er farligere for barn enn vaksiner. (ekstern lenke)

Vitenskapelig artikkel

• Iversen, Arild; Blomberg, Bjørn; Haug, Kjell et al. (2024). Symptom trajectories of post-COVID sequelae in patients with acute Delta or Omicron infection in Bergen, Norway. (ekstern lenke)
• Bredholt, Geir; Sævik, Marianne; Søyland, Hanne et al. (2024). Three doses of Sars-CoV-2 mRNA vaccine in older adults result in similar antibody responses but reduced cellular cytokine responses relative to younger adults. (ekstern lenke)
• Zhou, Fan; Vahokoski, Juha; Langeland, Nina et al. (2024). Impact of ageing on homologous and human-coronavirus-reactive antibodies after SARS-CoV-2 vaccination or infection. (ekstern lenke)
• Hoen, Lukas Anders Kryger; Jalloh, Sarah Larteley Lartey; Zhou, Fan et al. (2024). Impact of Pre-Existing Immunity and Age on Antibody Responses to Live Attenuated Influenza Vaccine. (ekstern lenke)
• Torgauten, Hilde Marie; Onyango, Therese Bredholt; Ljostveit, Sonja et al. (2024). Hospitalisations and humoral COVID-19 vaccine response in vaccinated rituximab-treated multiple sclerosis patients. (ekstern lenke)
• Salmanton-García, Jon; Wipfler, Pauline; Valle-Simón, Paula et al. (2023). VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe. (ekstern lenke)
• Waldock, Joanna; Remarque, Edmond J.; Zheng, Lingyi et al. (2023). Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study. (ekstern lenke)
• Argyropoulos, Christos D.; Leckler, Janina; Salmanton-García, Jon et al. (2023). Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit. (ekstern lenke)
• Beukema, Martin; Gong, Shuran; Al-Jaawni, Kasem et al. (2023). Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice. (ekstern lenke)
• Hansen, Lena; McMahon, Meagan; Turner, Hannah L. et al. (2023). Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo. (ekstern lenke)
• Hansen, Lena; Brokstad, Karl Albert; Bansal, Amit et al. (2023). Durable immune responses after BNT162b2 vaccination in home-dwelling old adults. (ekstern lenke)
• Ertesvåg, Nina Urke; Iversen, Arild; Blomberg, Bjørn et al. (2023). Post COVID-19 condition after delta infection and omicron reinfection in children and adolescents. (ekstern lenke)
• Waldock, Joanna; Weiss, Carol D.; Wang, Wei et al. (2023). An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study. (ekstern lenke)
• Onyango, Therese Bredholt; Zhou, Fan; Bredholt, Geir et al. (2023). SARS-CoV-2 specific immune responses in overweight and obese COVID-19 patients. (ekstern lenke)
• Waerlop, Gwenn; Leroux-Roels, Geert; Pagnon, Anke et al. (2023). Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols. (ekstern lenke)
• Kenny, Grace; O’Reilly, Sophie; Wrigley Kelly, Neil et al. (2023). Distinct receptor binding domain IgG thresholds predict protective host immunity across SARS-CoV-2 variants and time. (ekstern lenke)
• Wolff, Anette Susanne Bøe; Hansen, Lena; Grytaas, Marianne Aardal et al. (2023). Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies. (ekstern lenke)
• Poulimeneas, Dimitrios; Koniordou, Markela; Kousi, Dimitra et al. (2023). The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium. (ekstern lenke)
• Bansal, Amit; Trieu, Mai Chi; Mohn, Kristin Greve-Isdahl et al. (2023). Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers. (ekstern lenke)
• Tran, Trung; Vaage, Eline Benno; Mehta, Adi et al. (2022). Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants. (ekstern lenke)
• Kittang, Bård Reiakvam; Blomberg, Bjørn; Sævik, Marianne et al. (2022). SARS CoV-2 Infection among Health Care Workers from Different Health Care Facilities in Western Norway: A Prospective, Cross-Sectional Study. (ekstern lenke)
• Salmanton-García, Jon; Stewart, Fiona A.; Heringer, Sarah et al. (2022). VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment. (ekstern lenke)
• Sicca, Federica; Sakorafa, Eleni; de Jonge, Anouk et al. (2022). The evolution of humoral immune responses to past and novel influenza virus strains gives evidence for antigenic seniority. (ekstern lenke)
• Ertesvåg, Nina Urke; Cox, Rebecca Jane; Jalloh, Sarah Larteley Lartey et al. (2022). Seasonal influenza vaccination expands hemagglutinin-specific antibody breadth to older and future A/H3N2 viruses. (ekstern lenke)
• Ertesvåg, Nina Urke; Xiao, Julie; Zhou, Fan et al. (2022). A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. (ekstern lenke)
• Luís, Catarina; Di Marzo, Verónica Romina; Kaur, Mandeep et al. (2022). Vaccination rates in Europe are not associated with online media intensity. (ekstern lenke)
• Waerlop, Gwenn; Leroux-Roels, Geert; Lambe, Teresa et al. (2022). Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium. (ekstern lenke)
• Begue, Sarah; Waerlop, Gwenn; Salaun, Bruno et al. (2022). Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4⁺ T cell immunity within the FLUCOP consortium. (ekstern lenke)
• Bernard, Marie-Clotilde; Waldock, Joanna; Commandeur, Sylvie et al. (2022). Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study. (ekstern lenke)
• Syre, Heidi; Obreque, Marius Eduardo Brå; Dalen, Ingvild et al. (2022). The performances of three commercially available assays for the detection of SARS‐CoV‐2 antibodies at different time points following SARS‐CoV‐2 infection. (ekstern lenke)
• Zimmermann, Julie; Schmidt, Signe Tandrup; Trebbien, Ramona et al. (2022). A Novel Prophylaxis Strategy Using Liposomal Vaccine Adjuvant CAF09b Protects against Influenza Virus Disease. (ekstern lenke)
• Mohn, Kristin Greve-Isdahl; Bredholt, Geir; Zhou, Fan et al. (2022). Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. (ekstern lenke)
• Ekanger, Camilla Tvedt; Zhou, Fan; Bohan, Dana et al. (2022). Human organotypic airway and lung organoid cells of bronchiolar and alveolar differentiation are permissive to infection by influenza and SARS-CoV-2 respiratory virus. (ekstern lenke)
• Fjelltveit, Elisabeth Berg; Blomberg, Bjørn; Kuwelker, Kanika et al. (2022). Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study. (ekstern lenke)
• Meskell, Pauline; Biesty, Linda M; Dowling, Maura et al. (2022). Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis. (ekstern lenke)
• Madsen, Anders; Jul-Larsen, Åsne; Trieu, Mai Chi et al. (2021). Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response. (ekstern lenke)
• Paramsothy, Abira; Jalloh, Sarah Larteley Lartey; Davies, Richard Allan et al. (2021). Humoral and cellular immune responses in critically ill influenza A/H1N1-infected patients. (ekstern lenke)
• Blomberg, Bjørn; Mohn, Kristin Greve-Isdahl; Brokstad, Karl Albert et al. (2021). Long COVID in a prospective cohort of home-isolated patients. (ekstern lenke)
• Kuwelker, Kanika; Zhou, Fan; Blomberg, Bjørn et al. (2021). Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study. (ekstern lenke)
• Fjelltveit, Elisabeth Berg; Cox, Rebecca Jane; Kittang, Bård Reiakvam et al. (2021). Lower antibiotic prescription rates in hospitalized COVID-19 patients than influenza patients, a prospective study. (ekstern lenke)
• Bansal, Amit; Trieu, Mai Chi; Mohn, Kristin Greve-Isdahl et al. (2021). Safety, Immunogenicity, Efficacy and Effectiveness of Inactivated Influenza Vaccines in Healthy Pregnant Women and Children Under 5 Years: An Evidence-Based Clinical Review. (ekstern lenke)
• Waldock, Joanna; Zheng, Lingyi; Remarque, Edmond J. et al. (2021). Assay harmonization and use of biological standards to improve the reproducibility of the hemagglutination inhibition assay: A FLUCOP collaborative study. (ekstern lenke)
• Hansen, Lena; Zhou, Fan; Amdam, Håkon et al. (2021). Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers. (ekstern lenke)
• Diaz Perez, Esperanza; Mamelund, Svenn-Erik; Eid, Jarle et al. (2021). Learning from the COVID-19 pandemic among migrants: An innovative, system-level, interdisciplinary approach is needed to improve public health . (ekstern lenke)
• Amdam, Håkon; Madsen, Anders; Zhou, Fan et al. (2021). Functional and Binding H1N1pdm09-Specific Antibody Responses in Occasionally and Repeatedly Vaccinated Healthcare Workers: A Five-Year Study (2009-2014). (ekstern lenke)
• Zhou, Fan; Hansen, Lena; Pedersen, Gabriel Kristian et al. (2021). Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With In Vivo Protection. (ekstern lenke)
• Trieu, Mai Chi; Bansal, Amit; Madsen, Anders et al. (2020). SARS-CoV-2-specific neutralizing antibody responses in Norwegian healthcare workers after the first wave of COVID-19 pandemic: a prospective cohort study. (ekstern lenke)
• Riese, Peggy; Trittel, Stephanie; Pathirana, Rishi et al. (2020). Responsiveness to influenza vaccination correlates with nkg2c-expression on nk cells. (ekstern lenke)
• Fjelltveit, Elisabeth Berg; Brokstad, Rebecca Jane Cox; Østensjø, Jørgen et al. (2020). Point-of-care influenza testing impacts clinical decision, patient flow and length of stay in hospitalized adults. (ekstern lenke)
• Pollard, Andrew J.; Sauerwein, Robert; Baay, Marc et al. (2020). Third human challenge trial conference, Oxford, United Kingdom, February 6–7, 2020, a meeting report. (ekstern lenke)
• Mohn, Kristin Greve Isdahl; Brokstad, Karl Albert; Islam, Shahinul et al. (2020). Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children. (ekstern lenke)
• Jalloh, Sarah Larteley Lartey; Zhou, Fan; Brokstad, Karl Albert et al. (2020). Live-attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction. (ekstern lenke)
• Madsen, Anders; Dai, Ya-Nan; McMahon, Meagan et al. (2020). Human antibodies targeting influenza B virus neuraminidase active site are broadly protective. (ekstern lenke)
• Björk, Albin; Thorlacius, Gudny Ella; Mofors, Johannes et al. (2020). Viral antigens elicit augmented immune responses in primary Sjögren's syndrome. (ekstern lenke)
• Bodin, Johanna Eva; Mihret, Adane; Holm-Hansen, Carol J C et al. (2019). Vitamin D Deficiency is Associated with Increased Use of Antimicrobials among Preschool Girls in Ethiopia. (ekstern lenke)
• Ianevski, Aleksandr; Zusinaite, Eva; Shtaida, Nastassia et al. (2019). Low temperature and low UV indexes correlated with peaks of influenza virus activity in Northern Europe during 2010-2018. (ekstern lenke)
• Madsen, Anders; Azimi, Linda; Tete, Sarah et al. (2019). No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination. (ekstern lenke)
• Krammer, Florian; Weir, Jerry P.; Engelhardt, Othmar et al. (2019). Meeting report and review: Immunological assays and correlates of protection for next-generation influenza vaccines. (ekstern lenke)
• Islam, Shahinul; Zhou, Fan; Jalloh, Sarah Larteley Lartey et al. (2019). Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination. (ekstern lenke)
• Bösl, Korbinian; Ianevski, Aleksandr; Than, Thoa T. et al. (2019). Common nodes of virus-host interaction revealed through an integrated network analysis. (ekstern lenke)
• Ianevski, Aleksandr; Zusinaite, Eva; Kuivanen, Suvi et al. (2018). Novel activities of safe-in-human broad-spectrum antiviral agents. (ekstern lenke)
• Olberg, Henning Kristian; Eide, Geir Egil; Cox, Rebecca Jane et al. (2018). Antibody response to seasonal influenza vaccination in patients with multiple sclerosis receiving immunomodulatory therapy. (ekstern lenke)
• Trombetta, Claudia Maria; Ulivieri, Cristina; Cox, Rebecca Jane et al. (2018). Impact of erythrocyte species on assays for influenza serology. (ekstern lenke)
• Trieu, Mai Chi; Zhou, Fan; Jalloh, Sarah Larteley Lartey et al. (2018). Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. (ekstern lenke)
• Tete, Sarah; Jul-Larsen, Åsne; Rostami, Sina et al. (2018). Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine. (ekstern lenke)
• Brokstad, Karl Albert; Fredriksen, Marita; Zhou, Fan et al. (2018). T follicular-like helper cells in the peripheral blood of patients with primary Sjögren's syndrome. (ekstern lenke)
• Tunheim, Gro; Laake, Ida; Robertson, Anna Hayman et al. (2018). Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness. (ekstern lenke)
• Trieu, Mai Chi; Jul-Larsen, Åsne; Sævik, Marianne et al. (2018). Antibody responses to influenza A/H1N1pdm09 virus after pandemic and seasonal influenza vaccination in healthcare workers: A 5-year follow-up study. (ekstern lenke)
• Savic, Miloje; Dembinski, Jennifer Lynn; Laake, Ida et al. (2017). Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy. (ekstern lenke)
• Jacobsen, Henning; Rajendran, Madhusudan; Choi, Angela et al. (2017). Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model. (ekstern lenke)
• Dembinski, Jennifer Lynn; Mihret, Adane; Solomon, Abebe Yimer et al. (2017). High prevalence of humoral and cellular immunity to influenza viruses in preschool children living in Addis Ababa, Ethiopia. (ekstern lenke)
• Mohn, Kristin Greve Isdahl; Zhou, Fan; Brokstad, Karl Albert et al. (2017). Boosting of cross-reactive and protection-associated T cells in children after live attenuated influenza vaccination. (ekstern lenke)
• Islam, Shahinul; Mohn, Kristin Greve Isdahl; Krammer, Florain et al. (2017). Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination. (ekstern lenke)
• Andersen, Tor Kristian; Zhou, Fan; Cox, Rebecca Jane et al. (2017). A DNA vaccine that targets hemagglutinin to antigen-presenting cells protects mice against H7 influenza. (ekstern lenke)
• Ebensen, Thomas; Debarry, Jennifer; Pedersen, Gabriel Kristian et al. (2017). Mucosal administration of cycle-di-nucleotide-adjuvanted virosomes efficiently induces protection against influenza H5N1 in mice. (ekstern lenke)
• Aase, Audun; Sommerfelt, Halvor; Petersen, Lizette Balle et al. (2016). Salivary IgA from the sublingual compartment as a novel noninvasive proxy for intestinal immune induction. (ekstern lenke)
• Dembinski, Jennifer Lynn; Savic, Miloje; Kim, Yohan et al. (2016). Epitope specific T-cell responses against influenza A in a healthy population. (ekstern lenke)
• Tete, Sarah; Krammer, Florain; Jalloh, Sarah Larteley Lartey et al. (2016). Dissecting the hemagglutinin head and stalk-specific IgG antibody response in healthcare workers following pandemic H1N1 vaccination. (ekstern lenke)
• Voltersvik, Pål; Aqrawi, Lara Adnan; Dudman, Susanne Gjeruldsen et al. (2016). Pulmonary changes in Norwegian fatal cases of pandemic influenza H1N1 (2009) infection: a morphologic and molecular genetic study. (ekstern lenke)
• Trieu, Mai Chi; Zhou, Fan; Jalloh, Sarah Larteley Lartey et al. (2016). Long-term maintenance of the influenza-specific cross-reactive memory CD4+ T-cell responses following repeated annual influenza vaccination.. (ekstern lenke)
• Eagan, Tomas Mikal; Hardie, Jon Andrew; Jul-Larsen, Åsne et al. (2016). Self-reported influenza vaccination and protective serum antibody titers in a cohort of COPD patients. (ekstern lenke)
• Héquet, Delphine; Pascual, Manuel; Lartey, Sarah Larteley et al. (2016). Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies. (ekstern lenke)
• Mohn, Kristin Greve Isdahl; Brokstad, Karl Albert; Pathirana, Rishi et al. (2016). Live attenuated influenza vaccine in children induces b-cell responses in tonsils. (ekstern lenke)
• Venkatesan, Sudhir; Cox, Rebecca Jane; Nguyen-Van-tam, Jonathan S. et al. (2016). Interpandemic (Seasonal) influenza. (ekstern lenke)
• Manenti, Alessandro; Tete, Sarah; Mohn, Kristin Greve Isdahl et al. (2016). Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination. (ekstern lenke)
• Mohn, Kristin Greve Isdahl; Bredholt, Geir; Brokstad, Karl Albert et al. (2015). Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. (ekstern lenke)
• Trondsen, Monica; Aqrawi, Lara Adnan; Zhou, Fan et al. (2015). Induction of local secretory IgA and multifunctional CD4+ T-helper cells following intranasal immunization with a H5N1 whole inactivated influenza virus vaccine in BALB/c mice. (ekstern lenke)
• Trombetta, Claudia Maria; Perini, Daniele; Vitale, Licia et al. (2015). Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses. (ekstern lenke)
• Major, Diane; Chichester, Jessica A.; Pathirana, Rishi et al. (2015). Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge. (ekstern lenke)
• Cox, Rebecca Jane; Major, Diane; Pedersen, Gabriel Kristian et al. (2015). Matrix M H5N1 vaccine induces cross-H5 clade humoral immune responses in a randomized clinical trial and provides protection from highly pathogenic influenza challenge in ferrets. (ekstern lenke)
• Panapasa, Jack Alwin; Cox, Rebecca Jane; Mohn, Kristin Greve Isdahl et al. (2015). The expression of B & T cell activation markers in children’s tonsils following live attenuated influenza vaccine. (ekstern lenke)
• Lartey, Sarah Larteley; Pathirana, Rishi; Zhou, Fan et al. (2015). Single dose vaccination of the ASO3-adjuvanted A (H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains. (ekstern lenke)
• Koch, Anne Mette; Nilsen, Roy Miodini; Dalheim, Anne et al. (2015). Need for more targeted measures - Only less severe hospital-associated infections declined after introduction of an infection control program. (ekstern lenke)
• Wohlbold, Teddy John; Nachbagauer, Raffael; Xu, Haoming et al. (2015). Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. (ekstern lenke)
• Eidem, Synnøve; Tete, Sarah; Jul-Larsen, Åsne et al. (2015). Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations. (ekstern lenke)
• Koch, Anne Mette; Nilsen, Roy Miodini; Eriksen, Hanne-Merete et al. (2015). Mortality related to hospital-associated infections in a tertiary hospital; repeated cross-sectional studies between 2004-2011. (ekstern lenke)
• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane; Tunheim, Gro et al. (2015). Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway. (ekstern lenke)
• Sridhar, Saranya; Brokstad, Karl Albert; Cox, Rebecca Jane (2015). Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines. (ekstern lenke)
• Mair-Jenkins, John; Saavedra-Campos, Maria; Baillie, J. Kenneth et al. (2015). The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis. (ekstern lenke)
• Krammer, Florian; Jul-Larsen, Åsne; Margine, Irina et al. (2014). An H7N1 influenza virus vaccine induces broadly reactive antibody responses against H7N9 in humans. (ekstern lenke)
• Skrede, Steinar; Steinsland, Hans; Sommerfelt, Halvor et al. (2014). Experimental infection of healthy volunteers with enterotoxigenic Escherichia coli wild-type strain TW10598 in a hospital ward. (ekstern lenke)
• Pedersen, Gabriel; Höschler, Katja; Solbak, Sara Marie Øie et al. (2014). Serum IgG titres, but not avidity, correlates with neutralizing antibody response after H5N1 vaccination. (ekstern lenke)
• Mann, Alex; Noulin, Nicolas; Catchpole, Andrew et al. (2014). Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge. (ekstern lenke)
• Olberg, Henning Kristian; Cox, Rebecca Jane; Nøstbakken, Jane Kristin et al. (2014). Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: An explorative study. (ekstern lenke)
• Krammer, Florian; Albrecht, Randy A.; Tan, Gene S. et al. (2014). Divergent H7 immunogens offer protection from H7N9 virus challenge. (ekstern lenke)
• Pedersen, Gabriel Kristian; Sjursen, Haakon; Nøstbakken, Jane Kristin et al. (2014). Matrix M™ adjuvanted virosomal H5N1 vaccine induces balanced Th1/Th2 CD4+ T cell responses in man. (ekstern lenke)
• Nachbagauer, Raffael; Wohlbold, Teddy John; Hirsh, Ariana et al. (2014). Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. (ekstern lenke)
• Pidelaserra Marti, Gemma; Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane et al. (2014). The Influence of Tonsillectomy on Total Serum Antibody Levels. (ekstern lenke)
• Svindland, Signe; Pedersen, Gabriel Kristian; Pathirana, Rishi et al. (2013). A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. (ekstern lenke)
• Pedersen, Gabriel; Madhun, Abdullah Sami; Breakwell, Lucy et al. (2012). T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. (ekstern lenke)
• Svindland, Signe; Jul-Larsen, Åsne; Pathirana, Rishi et al. (2012). The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine. (ekstern lenke)
• Jul-Larsen, Åsne; Madhun, Abdullah Sami; Brokstad, Karl Albert et al. (2012). The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants. (ekstern lenke)
• Pathirana, Rishi; Bredholt, Geir; Akselsen, Per Espen et al. (2012). A(H1N1)pdm09 Vaccination of Health Care Workers: Improved Immune Responses in Low Responders Following Revaccination. (ekstern lenke)
• Simonsen, Kristian Anton; Hunskaar, Steinar; Wensaas, Knut-Arne et al. (2012). Influenza-like illness in general practice in Norway: clinical course and attitudes towards vaccination and preventive measures during the 2009 pandemic. (ekstern lenke)
• Pedersen, Gabriel; Ebensen, Thomas; Gjeraker, Ingrid Hjetland et al. (2011). Evaluation of the sublingual route for administration of influenza H5N1 virosomes in combination with the bacterial second messenger c-di-GMP. (ekstern lenke)
• Cox, Rebecca Jane; Pedersen, Gabriel; Madhun, Abdullah Sami et al. (2011). Evaluation of a virosomal H5N1 vaccine formulated with Matrix M (TM) adjuvant in a phase I clinical trial. (ekstern lenke)
• Pedersen, Gabriel; Halstensen, Alfred; Sjursen, Haakon et al. (2011). Pandemic influenza vaccination of hypogammaglobulinemic patients induces normal or elevated influenza-specific CD4+Th1-cell responses. (ekstern lenke)
• Pedersen, Gabriel; Halstensen, Alfred; Sjursen, Haakon et al. (2011). Pandemic Influenza Vaccination Elicits Influenza-Specific CD4(+) Th1-cell Responses in Hypogammaglobulinaemic Patients: Four case reports. (ekstern lenke)
• Pedersen, Gabriel; Major, Diane; Roseby, Sarah et al. (2011). Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model. (ekstern lenke)
• Madhun, Abdullah Sami; Haaheim, Lars Reinhardt; Nøstbakken, Jane Kristin et al. (2011). Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4(+) cells and strong mucosal and systemic antibody responses in mice. (ekstern lenke)
• Madhun, Abdullah Sami; Akselsen, Per Espen; Sjursen, Haakon et al. (2010). An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. (ekstern lenke)
• Cox, Rebecca Jane; Madhun, Abdullah Sami; Hauge, Solveig et al. (2009). A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. (ekstern lenke)
• Madhun, Abdullah Sami; Nilsen, Mona Vibece; Haaheim, Lars Reinhardt et al. (2009). Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice. (ekstern lenke)
• Cox, Rebecca Jane; Major, Diane; Hauge, Solveig et al. (2009). A cell-based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models. (ekstern lenke)
• Hovden, Arnt-Ove; Brokstad, Karl Albert; Major, Diane et al. (2009). A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice. (ekstern lenke)
• Hauge, Solveig; Madhun, Abdullah Sami; Cox, Rebecca Jane et al. (2007). Quality and kinetics of the antibody response in mice after three different low-dose influenza virus vaccination strategies. (ekstern lenke)
• Hauge, Solveig; Madhun, Abdullah Sami; Cox, Rebecca Jane et al. (2007). A comparison of the humoral and cellular immune responses at different immunological sites after split influenza virus vaccination of mice. (ekstern lenke)
• Cox, Rebecca Jane; Hovden, Arnt-Ove; Brokstad, Karl Albert et al. (2006). The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. (ekstern lenke)
• Cox, Rebecca Jane; Haaheim, Lars Reinhardt; Eriksson, Jens Christian et al. (2006). The humoral and cellular responses induced locally and systematically after parenteral influenza vaccination in man. (ekstern lenke)
• Szyszko, Ewa Alicja; Brokstad, Karl Albert; Cox, Rebecca Jane et al. (2006). Impact of influenza vaccine formulation with a detailed analysis of the cytokine response. (ekstern lenke)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Madhun, Abdullah Sami et al. (2005). Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice. (ekstern lenke)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Haaheim, Lars Reinhardt (2005). Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice. (ekstern lenke)
• Brokstad, Karl Albert; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2002). Parenteral vaccination against influenza does not induce a local antigen-specific immune response in the nasal mucosa. (ekstern lenke)
• Cox, Rebecca Jane; Mykkeltvedt, E; Robertson, J et al. (2002). Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication. (ekstern lenke)
• Brokstad, Rebecca Jane Cox; Mykkelstveit, Eva; Robertson, James et al. (2001). Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication. (ekstern lenke)
• Brokstad, Rebecca Jane Cox; Mykkelstveit, Eva; Sjursen, Haakon et al. (2001). The effect of zanamivir treatment on the early immune response to influenza vaccination. (ekstern lenke)
• Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox; Eriksson, Jens-Christian et al. (2001). High prevalence of influenza specific antibody secreting cells in nasal mucosa. (ekstern lenke)

Vitenskapelig oversiktsartikkel/review

• Cox, Rebecca Jane; Pathirana, Rishi Delan (2024). Unravelling influenza correlates of protection: lessons from human A/H1N1 Challenge. (ekstern lenke)
• Meskell, Pauline; Biesty, Linda M; Dowling, Maura et al. (2023). Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis. (ekstern lenke)
• McKimm-Breschkin, Jennifer L.; Hay, Alan J.; Cao, Bin et al. (2022). COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference. (ekstern lenke)
• Moore, Kristine A.; Ostrowsky, Julia T.; Kraigsley, Alison M. et al. (2021). A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future. (ekstern lenke)
• Madsen, Anders; Brokstad, Rebecca Jane Cox (2020). Prospects and challenges in the development of universal influenza vaccines. (ekstern lenke)
• Zhou, Fan; Trieu, Mai Chi; Davies, Richard Allan et al. (2018). Improving influenza vaccines: challenges to effective implementation. (ekstern lenke)
• Slettevoll, Steffen Aleksander; Parasomthy, Abira; Cox, Rebecca Jane (2018). Influensa-alltid relevant . (ekstern lenke)
• Mohn, Kristin Greve Isdahl; Smith, Ingrid; Sjursen, Haakon et al. (2017). Immune responses after live attenuated influenza vaccination . (ekstern lenke)
• Krammer, Florian; Cox, Rebecca Jane (2013). The emergence of H7N9 viruses: A chance to redefine correlates of protection for influenza virus vaccines. (ekstern lenke)
• Haaheim, Lars Reinhardt; Madhun, Abdullah Sami; Cox, Rebecca Jane (2009). Pandemic influenza vaccines - the challenges. (ekstern lenke)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Haaheim, Lars Reinhardt (2007). Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients. (ekstern lenke)
• Cox, Rebecca Jane; Brokstad, Karl; Ogra, Pearay (2004). Influenza virus: Immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines. (ekstern lenke)

Vitenskapelig foredrag

• Cox, Rebecca Jane (2023). Local Immunity After Influenza Vaccination. (ekstern lenke)
• Cox, Rebecca Jane (2023). Indo-European Consortium for Next Generation Influenza Vaccine Innovation. (ekstern lenke)
• Cox, Rebecca Jane (2023). Post COVID-19 condition in children and adolescents after delta infection and omicron reinfection. (ekstern lenke)
• Cox, Rebecca Jane (2022). SARS CoV-2 vaccines, what have we learnt and what is the future . (ekstern lenke)
• Cox, Rebecca Jane (2022). Covid-19 vaccine evaluation. (ekstern lenke)
• Cox, Rebecca Jane (2021). Influenza and SARS-CoV-2 vaccines and the young immune system: should we vaccinate children. (ekstern lenke)
• Cox, Rebecca Jane (2021). Pre-existing immunity and correlates of protection for Influenza. (ekstern lenke)
• Cox, Rebecca Jane (2021). Covid-19 i Bergen. (ekstern lenke)
• Cox, Rebecca Jane (2020). Case study: Influenza; impact of pre-existing immunity on study end points . (ekstern lenke)
• Cox, Rebecca Jane (2020). COVID-19 in the community and health care system in Bergen . (ekstern lenke)
• Cox, Rebecca Jane (2020). COVID-19 in the community and health care system in Bergen, Norway. (ekstern lenke)
• Cox, Rebecca Jane (2020). Influensa. (ekstern lenke)
• Cox, Rebecca Jane (2019). Immune responses to influenza A/H1N1pdm09 virus after adjuvanted pandemic and seasonal influenza vaccination in healthcare workers. (ekstern lenke)
• Bösl, Korbinian; Ianevski, Aleksandr; Than, Thoa T. et al. (2019). Critical Nodes of Viral Modulation Revealed Through an Integrated Network Analysis of Host-Virus Interaction Landscape. (ekstern lenke)
• Cox, Rebecca Jane (2018). Should we annually vaccinate health care workers against influenza?. (ekstern lenke)
• Cox, Rebecca Jane (2018). Hvorfor trenger vi fremdeles vaksiner? og Influensa en evig kamp. . (ekstern lenke)
• Cox, Rebecca Jane (2018). Subject selection and screening for susceptibility to challenge. (ekstern lenke)
• Cox, Rebecca Jane (2018). Should we vaccinate health care workers against influenza annually?. (ekstern lenke)
• Cox, Rebecca Jane (2018). Using human influenza vaccine studies to define next generation vaccines . (ekstern lenke)
• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane; Zhou, Fan et al. (2015). Cellular immune responses after live attenuated influenza vaccination in children, a clinical trial.. (ekstern lenke)
• Trogstad, Lill; Mjaaland, Siri; Molden, Tor et al. (2014). Perinatal outcomes and children’s health after prenatal exposure to influenza infection and vaccination. (ekstern lenke)
• Savic, Miloje; Laake, Ida; Dembinski, Jennifer Lynn et al. (2014). The Norwegian Influenza cohort (NorFlu): immune responses in pdmH1N1 exposed versus non-exposed pregnant women. (ekstern lenke)
• Savic, Miloje; Laake, Ida; Dembinski, Jennifer Lynn et al. (2014). The Norwegian Influenza cohort study (NorFlu): immune responses in H1N1 pdm exposed versus non-exposed pregnant women. (ekstern lenke)
• Cox, Rebecca Jane; Eriksson, Jens-Christian Haug; Madhun, Abdullah Sami et al. (2005). The humoral and cellular responses induced locally and systemically after parenteral influenza vaccination in man. (ekstern lenke)
• Haaheim, Lars Reinhardt; Cox, Rebecca Jane; Brokstad, Karl Albert et al. (2004). The antibody response to parenteral influenza vaccination � A review of specificity, magnitude, rapidity and shortcomings. (ekstern lenke)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (ekstern lenke)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (ekstern lenke)
• Brokstad, Karl; Brokstad, Rebecca Jane Cox; Eriksson, Jens-Christian et al. (2002). Influenzaantigenspecific cells in human nasal mucosa. (ekstern lenke)
• Brokstad, Karl; Davidsson, Åke; Eriksson, Jens-Christian et al. (2002). Influenza specific antibody secreting cells in nasal mucosa. (ekstern lenke)
• Brokstad, Karl; Davidsson, Åke; Eriksson, Jens-Christian et al. (2002). Influenza-specific antibody producing cells in human nasal mucosa. (ekstern lenke)
• Brokstad, Karl Albert; Davidsson, Åke; Eriksson, Jens-Christian et al. (2002). Influenza-specific antibody producing cells in human nasal mucosa. (ekstern lenke)
• Eriksson, Jens-Christian; Brokstad, Karl; Brokstad, Rebecca Jane Cox et al. (2002). Influenza specific antibodysecreting cells in nasal mucosa, prior to and after vaccination. (ekstern lenke)
• Davidsson, Åke; Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox et al. (2001). Influensaantigenspecifika, antikroppsproducerande lymfocyter i human nasal slemhinne. (ekstern lenke)
• Brokstad, Rebecca Jane Cox; Mykkelstveit, Eva; Haaheim, Lars Reinhardt (2001). DNA vaccination with HA or NP encoding plasmids results in rapid viral clearance after viral challenge. (ekstern lenke)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2001). Influenza specific antibody secreting cells (I-ASC)in human nasal mucosa. Relation to tonsil, blood and parenteral vaccination. (ekstern lenke)
• Davidsson, Åke; Eriksson, Jens-Christian; Cox, Rebecca Jane et al. (2001). The level of influenzaspecific antibodysecreting cells in nasal mucosa, prior to an after vaccination. (ekstern lenke)
• Brokstad, Karl Albert; Cox, Rebecca Jane; Eriksson, Jens-Christian et al. (2001). The basal level of influenza specific antibody secreting cells in healthy subjects. (ekstern lenke)
• Brokstad, Rebecca Jane Cox; Mykkelstveit, Eva; Sjursen, Haakon et al. (2001). The effect of relenza treatment on the early immune response induced after influenza vaccination. (ekstern lenke)
• Haaheim, Lars Reinhardt; Ibsen, Margrethe W.; Skogstrand, Monica et al. (2001). Antibodies from lymphocytes used as diagnostic markers: A novel approach. (ekstern lenke)

Poster

• Yddal, Ingeborg; Lartey, Sarah; Bansal, Amit et al. (2023). Immunogenicity after influenza-vaccine in young children and pregnant women in rural Bangladesh. (ekstern lenke)
• Yddal, Ingeborg; Lartey, Sarah Larteley; Bansal, Amit et al. (2023). Influenza-specific antibody responses after Influenza vaccination in young children and pregnant women in rural Bangladesh. (ekstern lenke)
• Hansen, Lena; Zhou, Fan; Amdam, Håkon et al. (2019). Neuraminidase antibody responses after pandemic and seasonal influenza vaccinations: a five-year study. (ekstern lenke)
• Ertesvåg, Nina; Trieu, Mai Chi; Cox, Rebecca Jane (2019). Seasonal influenza vaccination induces broad antibody responses against antigenically distinct A/H3N2 viruses. (ekstern lenke)
• Hansen, Lena; Zhou, Fan; Cox, Rebecca Jane (2019). Neuraminidase Antibody Responses After Pandemic And Seasonal Vaccination: A Five-Year Study. (ekstern lenke)
• Ertesvåg, Nina; Trieu, Mai Chi; Cox, Rebecca Jane (2019). Seasonal Influenza Vaccination Induces Cross-Reactive Antibodies Against A/H3N2 Viruses. (ekstern lenke)
• Savic, Miloje; Dembinski, Jennifer Lynn; Laake, Ida et al. (2016). The Norwegian Influenza cohort (NorFlu): immune responses in pregnant women during the 2009 H1N1 influenza A pandemic. (ekstern lenke)
• Savic, Miloje; Dembinski, Jennifer Lynn; Laake, Ida et al. (2016). Cellular correlates of protection against A(H1N1)pdm09 pandemic influenza during pregnancy. (ekstern lenke)
• Trogstad, Lill; Mjaaland, Siri; Molden, Tor et al. (2014). Perinatal outcomes and children’s health after prenatal exposure to influenza infection and vaccination. (ekstern lenke)
• Mjaaland, Siri; Håberg, Siri Eldevik; Dembinski, Jennifer Lynn et al. (2013). Perinatal outcomes and children’s health after prenatal exposure to influenza infection and vaccination. (ekstern lenke)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Brokstad, Karl Albert et al. (2007). Immunisation of mice with whole inactivated avian influenza H7N1 virus vaccine. (ekstern lenke)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Madhun, Abdullah Sami et al. (2005). The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. (ekstern lenke)
• Cox, Rebecca Jane; Hovden, Arnt-Ove; Madhun, Abdullah Sami et al. (2005). The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice. (ekstern lenke)
• Madhun, Abdullah Sami; Szyszko, E; Cox, Rebecca Jane et al. (2005). The cytokine and the antibody responses after vaccination with influenza split or whole virus vaccines in mice. (ekstern lenke)
• Brokstad, Karl Albert; Eriksson, Jens-Christian Haug; Cox, Rebecca Jane et al. (2005). Cytokine profile and lymphocyte pattern influenced by parenteral influenza vaccination. (ekstern lenke)
• Hovden, Arnt-Ove; Brokstad, Rebecca Jane Cox; Haaland, Inger Marie et al. (2004). The humoral immune response in mice after vaccination and subsequent challenge with live influenza virus. (ekstern lenke)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (ekstern lenke)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (ekstern lenke)
• Brokstad, Rebecca Jane Cox; Hovden, Arnt Ove; Bragstad, Karoline et al. (2003). Comparison of the humoral immune response to split and whole virus vaccines in mice. (ekstern lenke)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). The local and systemic immune response to parenterally administered inactivated influenza vaccine. (ekstern lenke)
• Davidsson, Åke; Eriksson, Jens-Christian; Brokstad, Rebecca Jane Cox et al. (2003). Local and systemic immune response to inactivated influenza vaccine. (ekstern lenke)
• Hovden, Arnt Ove; Brokstad, Rebecca Jane Cox; Haaheim, Lars Reinhardt (2003). The immune response to H7N1 whole virus vaccine in mice. (ekstern lenke)
• El-Madhun, Abdullah; Brokstad, Rebecca Jane Cox; Haaheim, Lars Reinhardt et al. (2003). The kinetics of the systemic and local immune response to parenteral influenza vaccination. (ekstern lenke)
• Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox; Eriksson, Jens-Christian et al. (2002). Influenzaantigenspecific cells in human nasal mucosa. (ekstern lenke)
• Eriksson, Jens-Christian; Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox et al. (2002). Influenzaspecific antibodysecreting cells in nasal mucosa, prior to and after vaccination. (ekstern lenke)
• Brokstad, Karl Albert; Davidsson, Åke; Eriksson, Jens-Christian et al. (2002). Influenza specific antibody secreting cells in nasal mucosa. (ekstern lenke)

Errata

• Tran, Trung; Vaage, Eline Benno; Mehta, Adi et al. (2023). Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants (npj Vaccines, (2022), 7, 1, (174), 10.1038/s41541-022-00586-7). (ekstern lenke)
• Trieu, Mai Chi; Zhou, Fan; Jalloh, Sarah Larteley Lartey et al. (2018). Publisher Correction: Augmented CD4+ T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years. (ekstern lenke)

Brev til redaktøren

• Mohn, Kristin Greve-Isdahl; Bredholt, Geir; Onyango, Therese Bredholt et al. (2023). SARS-CoV-2 infection induces long-lived B and T-cell responses up to 15 months post-infection, irrespective of disease severity. (ekstern lenke)

Intervju

• Grødeland, Gunnveig; Cox, Rebecca Jane; Steenbuch, Bethen et al. (2023). Nå er vinterens smittebølge her: 77.000 sårbare barn er ikke vaksinert. (ekstern lenke)
• Cox, Rebecca Jane; Tøndel, Camilla; Spurkland, Anne et al. (2023). Bør alle norske barn vaksineres mot vannkopper?. (ekstern lenke)
• Steenbuch, Bethen; Grødeland, Gunnveig; Cox, Rebecca Jane et al. (2023). Venter smittetopp rundt nyttår. Slik kan influensasesongen bli fremover.. (ekstern lenke)
• Steenbuch, Bethen; Grødeland, Gunnveig; Cox, Rebecca Jane et al. (2023). Vaksine mot fugleinfluensa skal testes ut på mennesker i Norge. (ekstern lenke)
• Holthe, Klaus; Grødeland, Gunnveig; Cox, Rebecca Jane et al. (2022). Ny vaksinestudie: – Svært viktig. (ekstern lenke)
• Steenbuch, Bethen; Grødeland, Gunnveig; Cox, Rebecca Jane (2022). Til høsten kommer trolig en ny virusbølge. Men nå er vi mye bedre forberedt.. (ekstern lenke)
• Cox, Rebecca Jane (2021). Slik kan koronavaksinen beskytte oss mot den neste pandemien. (ekstern lenke)
• Cox, Rebecca Jane (2020). Kinesiske forskere har funnet flere risikofaktorer hos dem som døde. (ekstern lenke)
• Cox, Rebecca Jane (2020). Derfor har ikke sverige strengere krav. (ekstern lenke)
• Cox, Rebecca Jane (2020). Treng vi å frykte koronaviruse i noreg. (ekstern lenke)
• Cox, Rebecca Jane (2020). Hvor farlig er det nye, kinesiske koronaviruset?. (ekstern lenke)
• Cox, Rebecca Jane (2020). Oppfyller kriteriene for sykdom x. (ekstern lenke)
• Cox, Rebecca Jane (2020). Norsk koronastudie avslører langt høyere smitterisiko i familier enn tidligere påvist. (ekstern lenke)
• Cox, Rebecca Jane (2020). 19,5 millioner til koronaforskning ved uib. (ekstern lenke)
• Cox, Rebecca Jane (2020). Tegnell mener lite influensa forklarer høye koronatall dette svarer norske eksperter.. (ekstern lenke)
• Cox, Rebecca Jane (2020). Virusekspert om Trump-han spilte russisk-rulett. (ekstern lenke)
• Cox, Rebecca Jane (2020). influensaeksperten lar seg imponere av bergen. (ekstern lenke)
• Cox, Rebecca Jane (2020). Coronaviruset: Familien til Chen er isolert i Kina. (ekstern lenke)
• Cox, Rebecca Jane (2020). Hva skjer om du blir smittet av coronavirus?. (ekstern lenke)
• Cox, Rebecca Jane (2020). Ni spoersmaal og svar om coronaviruset. (ekstern lenke)
• Cox, Rebecca Jane (2020). 10 kjappe om coronaviruset. (ekstern lenke)
• Cox, Rebecca Jane (2020). Wuhan-viruset sprer seg. Nå tas det drastiske grep over hele verden. (ekstern lenke)
• Cox, Rebecca Jane (2020). Hysteri samanlikna med dei gløymde krisene. (ekstern lenke)
• Cox, Rebecca Jane (2020). 45 i isolasjon på Landås etter skiferie. (ekstern lenke)
• Cox, Rebecca Jane (2020). Bør du unngå å ta buss og er koronaviruset farlig for gravide?. (ekstern lenke)
• Cox, Rebecca Jane (2020). Professor om coronaviruset: – Ingen grunn til å bekymre seg for covid-19. (ekstern lenke)
• Cox, Rebecca Jane; Mohn, Kristin Greve Isdahl (2019). Dette appa­ratet kan på 15 minutter finne ut om du har influ­ensa. (ekstern lenke)
• Cox, Rebecca Jane (2018). Man flu. Dette mener ekspertene om «man flu». (ekstern lenke)
• Cox, Rebecca Jane (2017). Influensasesong. (ekstern lenke)
• Cox, Rebecca Jane (2017). Årlege influensavaksiner hindrar ikkje naturleg immunitet. (ekstern lenke)
• Cox, Rebecca Jane (2017). 3000 prøver gav trygge svar om influensavaksinen . (ekstern lenke)
• Cox, Rebecca Jane (2017). Årlege influensavaksiner hindrar ikkje naturleg immunitet. (ekstern lenke)
• Cox, Rebecca Jane (2017). Årlege influensavaksinar hindrar ikkje naturleg immunitet. (ekstern lenke)
• Øystese, Oddgeir; Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2014). Behandling med Tamiflu reduserte mortaliteten under Pandemien i 2009. (ekstern lenke)

Leder

• Schotsaert, Michael; Cox, Rebecca Jane; Mallett, Corey P. (2022). Editorial: Pandemic influenza vaccine approaches: Current status and future directions. (ekstern lenke)
• Cox, Rebecca Jane (2013). Correlates of protection to influenza virus, where do we go from here?. (ekstern lenke)
• Pedersen, Gabriel; Cox, Rebecca Jane (2012). The mucosal vaccine quandary Intranasal vs. sublingual immunization against influenza. (ekstern lenke)
• Cox, Rebecca Jane; Brokstad, Karl Albert; Haaheim, Lars Reinhardt (2006). Pandemic influenza vaccine development: time is of the essence. (ekstern lenke)
• Cox, Rebecca Jane; Brokstad, Karl Albert; Haaheim, Lars Reinhardt (2006). Pandernic influenza vaccine development: time is of the essence. (ekstern lenke)

Populærvitenskapelig foredrag

• Cox, Rebecca Jane (2022). Post Corona: Samfunn og Helse - Hva er effektene og ettervirkningene? . (ekstern lenke)
• Cox, Rebecca Jane (2021). COVID-19 studie på Vestlandet. (ekstern lenke)
• Cox, Rebecca Jane (2019). Hva er god helse? Når skolemedisin møter vaksinemotstand. (ekstern lenke)
• Cox, Rebecca Jane (2017). Hvorfor trenger vi fortsatt vaksiner?. (ekstern lenke)
• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2015). Ytringsfrihet. (ekstern lenke)

Intervju tidsskrift

• Westin, Steinar; Cox, Rebecca Jane (2021). Klemmene på innsettelsen av Joe Biden skaper reaksjoner: Disse smittegrepene redder dem.. (ekstern lenke)
• Cox, Rebecca Jane (2017). 3000 prøver gav trygge svar om influensavaksinen . (ekstern lenke)

Fagartikkel

• Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox (2021). SARS-CoV-2; Mutasjoner og Varianter. . (ekstern lenke)
• Brokstad, Karl Albert; Cox, Rebecca Jane (2021). SARS-CoV-2; livssyklus, mutasjoner, immunreaksjoner og vaksiner. (ekstern lenke)
• Sjursen, Haakon; Talhaug, Kristine Livsdatter Aukland; Mohn, Kristin Greve Isdahl et al. (2018). Immunrespons etter levende svekket influensavksine. (ekstern lenke)

Short communication

• Brokstad, Rebecca Jane Cox; Brokstad, Karl Albert; Krammer, Florian et al. (2020). Seroconversion in household members of COVID-19 outpatients.. (ekstern lenke)

Populærvitenskapelig artikkel

• Ertesvåg, Nina; Brokstad, Rebecca Jane Cox; Brokstad, Karl Albert (2020). COVID-19 og jakta på ein vaksine.. (ekstern lenke)
• Fjelltveit, Elisabeth Berg; Madsen, Anders; Cox, Rebecca Jane et al. (2018). Pandemivaksinen i 2009-en forberedelse til neste influensapandemi. (ekstern lenke)

Programdeltagelse

• Cox, Rebecca Jane (2020). Spørsmål og svar om koronaviruset. (ekstern lenke)

Doktorgradsavhandling

• Islam, Shahinul; Cox, Rebecca Jane (2019). Live Attenuated Influenza Vaccine (LAIV) Immunization in Children and Adults: Lesson for Development of Universal Influenza Vaccine. (ekstern lenke)
• Trieu, Mai Chi; Cox, Rebecca Jane (2018). Long-term immune response after pandemic and seasonal influenza vaccination in healthcare workers. (ekstern lenke)
• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2016). Immune response to influenza after vaccination and infection. (ekstern lenke)

Dokumentar

• Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2013). Målet er en livsvarig supervaksine mot influensa. (ekstern lenke)
• Hødnebø, Line; Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane (2013). Forskning på ny influensa vaksine for barn. (ekstern lenke)

Leserinnlegg

• Bredholt, Geir; Pedersen, Gabriel; Pathirana, Rishi et al. (2013). A(H1N1)pdm09 Vaccination of Healthcare Workers: Improved Immune Responses in Low Responders Following Revaccination Reply. (ekstern lenke)
• Wood, John; Schild, Geoffery; Cox, Rebecca Jane (2011). Lars R. Haaheim PhD (1945-2011) Obituary. (ekstern lenke)
• Hauge, Solveig; Madhun, Abdullah Sami; Brokstad, Karl Albert et al. (2009). The Immunogenicity of a Cell-derived H7N1 Split Influenza Virion Vaccine in Mice. (ekstern lenke)

Sammendrag/abstract

• Gjeraker, Ingrid Hjetland; Pedersen, Gabriel; Svindland, Signe et al. (2011). Comparison of Different Routes of Administration for Influenza Vaccines in a Murine Model. (ekstern lenke)
• Pedersen, Gabriel; Cox, Rebecca Jane (2011). Influenza Specific T-Cell Responses Predict Later Neutralizing Antibody Titres in a Phase 1 Clinical Trial of a Virosomal H5N1 Vaccine Adjuvanted with Matrix-M. (ekstern lenke)

Vitenskapelig Kapittel/Artikkel/Konferanseartikkel

• Madhun, Abdullah Sami; Cox, Rebecca Jane; Haaheim, Lars Reinhardt et al. (2004). The kinetics of the systemic and local immune response to parenteral influenza vaccination. (ekstern lenke)
• Cox, Rebecca Jane; Hovden, Arnt-Ove; Bragstad, Karoline et al. (2004). Comparison of the humoral immune response to split and whole virus vaccines in mice. (ekstern lenke)
• Hovden, Arnt-Ove; Cox, Rebecca Jane; Haaheim, Lars Reinhardt (2004). The immune response to H7N1 whole virus vaccine in mice. (ekstern lenke)
• Brokstad, Karl Albert; Brokstad, Rebecca Jane Cox; Haaheim, Lars Reinhardt (2003). Detection of antibodies to influenza virus in human mucosal tissues and fluids. (ekstern lenke)

Hovedfagsoppgave

• Haaland, Inger Marie; Cox, Rebecca Jane; Haaheim, Lars R. et al. (2004). The humoral immune response after influenza viral challenge of mice previously immunised with inactivated influenza vaccine. (ekstern lenke)

Se en full oversikt over publikasjoner i Cristin

2023-26 KlinBeForsk Interventions against Long-COVID in Norway (PanoramicNorway). 6 partners. Partner. Budget: 20 million NOK

2021-26 EU IMI2 Innovations to accelerate vaccine development vaccine development and manufacture (Inno4Vac). 41 partners. WP leader  Budget: €18.6 million. 

2021-24 EU H2020. European Corona Vaccine Trial Accelerator Platform. (Vaccelerate). 31 partners.  National coordinator and WP leader Budget: €12 million. 

2020-25 EU H2020 Indo-European Consortium for Next Generation Influenza Vaccine Innovation (INCENTIVE). 19 partners.  Partner PI children’s clinical trial. Budget: €6 million

2019-25 Research Council of Norway (RCN) An effectiveness trial (phase IV) to evaluate protection of children and pregnant women by influenza vaccine in rural Bangladesh. 3 Partners. Coordinator - RJ. Cox. Budget: 16.9 million NOK